Memorial Sloan Kettering Cancer Center;Yeda Research and Development Co., Ltd. at the Weizmann Institute of Science
发明人:
Jonathan COLEMAN,Philip A. WATSON,Kwanghee KIM,Avigdor SCHERZ
申请号：
US15924039
公开号：
US20180296675A1
申请日:
2018.03.16
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A method for treatment of prostate cancer or benign prostate hyperplasia by combination therapy comprising administering to a patient an androgen-deprivation therapy agent and a bacteriochlorophyll derivative followed by photodynamic therapy (PDT) or vascular-targeted photodynamic therapy (VTP).
